HPR215 Exploring the Efficacy, Safety, and Regulatory Approval of Priority Reviewed Innovative Drugs in China (2015-2023)
Abstract
Authors
Q Li N Peng H Zhou P Liu H Guan D Yao
Q Li N Peng H Zhou P Liu H Guan D Yao
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now